Cargando…
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
BACKGROUND: Ovarian small cell carcinoma, hypercalcaemic type (SCCOHT) is a rare and lethal disease affecting young women. As histological diagnosis is challenging and urgent, there is a clear need for a robust diagnostic test. While mutations in the chromatin-remodelling gene, SMARCA4, appear to be...
Autores principales: | Genestie, Catherine, Blanc-Durand, Félix, Auguste, Aurélie, Pautier, Patricia, Dunant, Ariane, Scoazec, Jean-Yves, Gouy, Sébastien, Morice, Philippe, Bentivegna, Enrica, Maulard, Amandine, LeFormal, Audrey, Devouassoux-Shisheboran, Mojgan, Leary, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028983/ https://www.ncbi.nlm.nih.gov/pubmed/31844183 http://dx.doi.org/10.1038/s41416-019-0687-z |
Ejemplares similares
-
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer
por: Leary, Alexandra, et al.
Publicado: (2020) -
Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?
por: Gouy, Sebastien, et al.
Publicado: (2017) -
Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types
por: Gouy, Sebastien, et al.
Publicado: (2017) -
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
por: Auguste, Aurélie, et al.
Publicado: (2020) -
Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer
por: Kubelac, Paul, et al.
Publicado: (2020)